Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Ellis, Lee David
and
Soanes, Kelly Howard
2012.
A larval zebrafish model of bipolar disorder as a screening platform for neuro-therapeutics.
Behavioural Brain Research,
Vol. 233,
Issue. 2,
p.
450.
Brunoni, Andre R.
Nunes, Maria Angélica
Figueiredo, Roberta
Barreto, Sandhi M.
Fonseca, Maria de Jesus Mendes da
Lotufo, Paulo A.
and
Benseñor, Isabela M.
2013.
Patterns of benzodiazepine and antidepressant use among middle-aged adults. The Brazilian longitudinal study of adult health (ELSA-Brasil).
Journal of Affective Disorders,
Vol. 151,
Issue. 1,
p.
71.
Divljaković, Jovana
Milić, Marija
Namjoshi, Ojas A.
Tiruveedhula, Veera V.
Timić, Tamara
Cook, James M.
and
Savić, Miroslav M.
2013.
βCCT, an antagonist selective for α1GABAA receptors, reverses diazepam withdrawal-induced anxiety in rats.
Brain Research Bulletin,
Vol. 91,
Issue. ,
p.
1.
Baldwin, David S
Aitchison, Katherine
Bateson, Alan
Curran, H Valerie
Davies, Simon
Leonard, Brian
Nutt, David J
Stephens, David N
and
Wilson, Sue
2013.
Benzodiazepines: Risks and benefits. A reconsideration.
Journal of Psychopharmacology,
Vol. 27,
Issue. 11,
p.
967.
Reisfield, Gary M.
and
Webster, Lynn R.
2013.
Benzodiazepines in Long-Term Opioid Therapy.
Pain Medicine,
Vol. 14,
Issue. 10,
p.
1441.
Baldwin, David S
Anderson, Ian M
Nutt, David J
Allgulander, Christer
Bandelow, Borwin
den Boer, Johan A
Christmas, David M
Davies, Simon
Fineberg, Naomi
Lidbetter, Nicky
Malizia, Andrea
McCrone, Paul
Nabarro, Daniel
O’Neill, Catherine
Scott, Jan
van der Wee, Nic
and
Wittchen, Hans-Ulrich
2014.
Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology.
Journal of Psychopharmacology,
Vol. 28,
Issue. 5,
p.
403.
Starcevic, Vladan
2014.
The reappraisal of benzodiazepines in the treatment of anxiety and related disorders.
Expert Review of Neurotherapeutics,
Vol. 14,
Issue. 11,
p.
1275.
Costa, Jéssica Pereira
de Oliveira, Guilherme Antônio L.
de Almeida, Antônia Amanda C.
Islam, Md.Torequl
de Sousa, Damião Pergentino
and
de Freitas, Rivelilson Mendes
2014.
Anxiolytic-like effects of phytol: Possible involvement of GABAergic transmission.
Brain Research,
Vol. 1547,
Issue. ,
p.
34.
Iannelli, Richard J.
Finlayson, A.J. Reid
Brown, Kimberly P.
Neufeld, Ron
Gray, Roland
Dietrich, Mary S.
and
Martin, Peter R.
2014.
Suicidal behavior among physicians referred for fitness-for-duty evaluation.
General Hospital Psychiatry,
Vol. 36,
Issue. 6,
p.
732.
Combs, Heidi
and
Markman, Jesse
2014.
Anxiety Disorders in Primary Care.
Medical Clinics of North America,
Vol. 98,
Issue. 5,
p.
1007.
Buoli, Massimiliano
Mauri, Massimo Carlo
and
Altamura, Alfredo Carlo
2014.
Pharmacokinetic evaluation of agomelatine for the treatment of generalised anxiety disorder.
Expert Opinion on Drug Metabolism & Toxicology,
Vol. 10,
Issue. 6,
p.
885.
Gould, Rebecca L.
Coulson, Mark C.
Patel, Natasha
Highton-Williamson, Elizabeth
and
Howard, Robert J.
2014.
Interventions for reducing benzodiazepine use in older people: meta-analysis of randomised controlled trials.
British Journal of Psychiatry,
Vol. 204,
Issue. 2,
p.
98.
Sim, Faye
Sweetman, Isabel
Kapur, Shitij
and
Patel, Maxine X
2015.
Re-examining the role of benzodiazepines in the treatment of schizophrenia: A systematic review.
Journal of Psychopharmacology,
Vol. 29,
Issue. 2,
p.
212.
Pollmann, André S.
Murphy, Andrea L.
Bergman, Joel C.
and
Gardner, David M.
2015.
Deprescribing benzodiazepines and Z-drugs in community-dwelling adults: a scoping review.
BMC Pharmacology and Toxicology,
Vol. 16,
Issue. 1,
Saarelainen, Laura
Taipale, Heidi
Koponen, Marjaana
Tanskanen, Antti
Tolppanen, Anna-Maija
Tiihonen, Jari
and
Hartikainen, Sirpa
2015.
The Incidence of Benzodiazepine and Related Drug Use in Persons with and without Alzheimer’s Disease.
Journal of Alzheimer's Disease,
Vol. 49,
Issue. 3,
p.
809.
Billioti de Gage, Sophie
Pariente, Antoine
and
Bégaud, Bernard
2015.
Is there really a link between benzodiazepine use and the risk of dementia?.
Expert Opinion on Drug Safety,
Vol. 14,
Issue. 5,
p.
733.
Zia, Anam
Kamaruzzaman, Shahrul Bahyah
and
Tan, Maw Pin
2015.
Polypharmacy and falls in older people: Balancing evidence-based medicine against falls risk.
Postgraduate Medicine,
Vol. 127,
Issue. 3,
p.
330.
Baumeister, David
Tojo, Luis M.
and
Tracy, Derek K.
2015.
Legal highs: staying on top of the flood of novel psychoactive substances.
Therapeutic Advances in Psychopharmacology,
Vol. 5,
Issue. 2,
p.
97.
Liebrenz, Michael
Gehring, Marie-Therese
Buadze, Anna
and
Caflisch, Carlo
2015.
High-dose benzodiazepine dependence: a qualitative study of patients’ perception on cessation and withdrawal.
BMC Psychiatry,
Vol. 15,
Issue. 1,
Cadogan, Cathal A
and
Ryder, Sheila A
2015.
Community pharmacists’ role in benzodiazepine supply in Ireland: a questionnaire of pharmacists’ views and experiences.
International Journal of Pharmacy Practice,
Vol. 23,
Issue. 6,
p.
415.
Comments
No Comments have been published for this article.